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Abstract
Background: Stage 5 chronic kidney disease (CKD-5) patients on haemodialysis (HD) are at high risk of accidental
falls. Previous research has shown that frailty is one of the primary contributors to the increased risk of falling in this
clinical population. However, HD patients often present with abnormalities of cardiovascular function such as
baroreflex impairment and orthostatic dysregulation of blood pressure (BP) which may also be implicated in the
aetiology of falling. Therefore, we aimed to explore the relative importance of frailty and cardiovascular function as
potential exercise-modifiable predictors of falls in these patients.
Methods: Ninety-three prevalent CKD-5 patients on HD from three Renal Units were recruited for this prospective
cohort study, which was conducted between October 2015 and August 2018. At baseline, frailty status was
assessed using the Fried’s frailty phenotype, while physical function was evaluated through timed up and go (TUG),
five repetitions chair sit-to-stand (CSTS-5), objectively measured physical activity, and maximal voluntary isometric
strength. Baroreflex and haemodynamic function at rest and in response to a 60° head-up tilt test (HUT-60°) were
also assessed by means of the Task Force Monitor. The number of falls experienced was recorded once a month
during 12 months of follow-up.
Results: In univariate negative binomial regression analysis, frailty (RR: 4.10, 95%CI: 1.60–10.51, p = 0.003) and other
physical function determinants were associated with a higher number of falls. In multivariate analysis however, only
worse baroreflex function (RR: 0.96, 95%CI: 0.94–0.99, p = 0.004), and orthostatic decrements of BP to HUT-60° (RR:
0.93, 95%CI: 0.87–0.99, p = 0.033) remained significantly associated with a greater number of falls. Eighty falls were
recorded during the study period and the majority of them (41.3%) were precipitated by dizziness symptoms, as
reported by participants.
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Conclusions: This prospective study indicates that cardiovascular mechanisms implicated in the short-term
regulation of BP showed a greater relative importance than frailty in predicting falls in CKD-5 patients on HD. A
high number of falls appeared to be mediated by a degree of cardiovascular dysregulation, as evidenced by the
predominance of self-reported dizziness symptoms.
Trial registration: ClinicalTrials.gov (trial registration ID: NCT02392299; date of registration: March 18, 2015).
Keywords: Stage 5 chronic kidney disease, Haemodialysis, Frailty, Physical function, Baroreflex function, Blood
pressure, Falls
Background
Stage 5 chronic kidney disease (CKD-5) patients receiv-
ing maintenance haemodialysis (HD) are at high risk of
falls and fall-related injuries [1–3], with incidence rates
being 1.5 to 3.5 times higher than community-dwelling
older adults [4–6]. The clinical implications of an acci-
dental fall can be devastating in this patient population
who are already multi-comorbid. Several prospective co-
hort studies conducted in HD patients have concluded
that those who fell had a 2.1 to 3.5 times higher risk of
admission to nursing homes, hospitalisation, and death
[7, 8]. Previous research has shown that factors such as
older age, comorbidity, polypharmacy and frailty seem to
be principal factors implicated in the aetiology of falls in
these patients [1, 2, 4, 7].
The prevalence of physical frailty in the CKD-5 popu-
lation is 36.8% and is approximately five-fold higher than
in community-dwelling older adults [9, 10]. From a pre-
ventive and rehabilitative point of view, this syndrome is
a potentially modifiable risk factor, as previous studies
conducted in HD populations have shown that single
frailty components, such as low physical activity, muscle
strength, and slow gait speed can be improved following
exercise-based interventions [11]. Although frailty has
been consistently shown to be associated with falls in
HD patients [4, 12, 13], few studies have explored the re-
lationship between objective frailty-related physical func-
tion measures and falls [1, 2, 4, 12, 14, 15]. Results from
these studies seem to indicate that, in predicting falls,
composite indices of physical function [14, 15] may be
more useful than single component assessments [2].
However, the identification of which individual frailty/
physical function components may be more closely asso-
ciated with falls is of paramount importance, as this
would eventually allow exercise-based rehabilitation pro-
grams to be tailored to reduce the occurrence of falls in
CKD-5 patients on HD. Along with frailty, cardiovascu-
lar disease (CVD) is also highly prevalent in CKD-5 pa-
tients and impaired cardiovascular function is associated
with multiple adverse clinical outcomes [16]. A few stud-
ies have also begun to better explore the link between
clinical outcomes such as falls and cardiovascular dys-
regulation in this patient group [5, 17, 18]. In particular,
it appears that the CKD-5 population on dialysis may be
at risk of hypotension that can lead to postural dizziness,
and potentially falls. This is further exacerbated by the
combined effect of autonomic failure and the significant
fluid shifts associated with dialysis [17]. Two studies re-
ported that low pre-dialysis blood pressure (BP) was as-
sociated with increased odds of falling [2, 19], and a
recent investigation by Kono et al. [15] highlighted a sig-
nificant relationship between intra-dialytic hypotension
and falls in HD patients. In addition, we recently postu-
lated that a drop in BP in response to a passive ortho-
static challenge, as well as impaired baroreflex function
may be linked to an increased risk of falling in HD pa-
tients [18]. All of these observations seem to indirectly
suggest that impaired BP control, to maintain haemo-
dynamic stability, might be implicated as an additional
factor in the aetiology of falls in the CKD-5 population
on dialysis, due to the CKD-related autonomic failure
and/or the dialysis-related hypotension. From a rehabili-
tation/therapeutic perspective, this could have important
translational impact, since the short-term regulation of
BP, as assessed by means of baroreflex function, has
been shown to improve following active interventions
such as exercise [20].
The objective of this investigation was to explore the
relative importance of frailty and cardiovascular function
as potential exercise-modifiable predictors of falls in
CKD-5 patients on HD. We hypothesised that 1) frailty
and cardiovascular function would be associated with a
higher number of falls, and that 2) modelling the risk of
falling by adding a cardiovascular function variable to
frailty would improve the prediction of falls sustained




An observational prospective study design was used to
investigate the association between potential predictors
of falls (e.g. frailty, cardiovascular function) and the
number of falls sustained over a 12-month follow-up
period in CKD-5 patients on HD.
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Study setting
The study was conducted in three National Health Ser-
vice (NHS) Renal Units located in North Lanarkshire
and Fife, United Kingdom, between October 2015 and
August 2018. Recruitment started in October 2015 and
continued on a rolling basis until December 2017. All
potential predictors and clinical variables were assessed
(during a single session of 2 hours duration) at baseline
for each participant between October 2015 and Decem-
ber 2017, while the follow-up period ran from November
2015 to August 2018.
This research project abided by the ethical principles for
medical research involving human participants, as set out
by the world medical association declaration of Helsinki,
and received ethical approval by the West of Scotland
NHS and Queen Margaret University Research Ethics
Committees (NHS REC reference number: 15/WS/0079).
This research project was prospectively registered in Clini-
calTrials.gov (trial registration ID: NCT02392299; date of
registration: March 18, 2015).
Study participants
Prevalent ambulatory CKD-5 patients stable on HD
therapy for at least 3 months, fluent in spoken and writ-
ten English, and ≥ 18 years of age were considered eli-
gible to participate in the study.
Exclusion criteria were lower limb amputation without
prosthesis, unstable dialysis and medication treatment,
unstable cardiac condition, clinically severe left ventricu-
lar outflow obstruction, suspected or known aneurysm,
critical mitral stenosis, critical cerebrovascular stenosis,
critical proximal coronary artery stenosis, pregnancy and
severe cognitive impairment.
All patients who agreed to take part in the study pro-
vided written informed consent.
Measurements
Demographic and clinical characteristics
Patient demographics (age, gender, height, weight, body
mass index), and clinical characteristics (dialysis vintage,
Charlson comorbidity index, medications) were ex-
tracted from the patients’ medical records. Height and
weight were measured on the assessment day.
Falls
A fall was operationally defined as an unexpected event
in which the participant comes to rest on the ground,
floor, or lower level [21]. One researcher (TZ) and two
research nurses (KC and NA) administered a customised
falls questionnaire to all study participants during dialy-
sis, once a month following baseline assessment, for a
period of 12 months. Information recorded included
number of falls experienced (if any), circumstances sur-
rounding these falls (i.e. location, activities undertaken
at the time of fall, precipitating factors), and their conse-
quences (i.e. hospitalisation, injuries, emergency services
etc.). A patient was classified as a “faller” if he/she re-
ported at least one fall during the 12-month longitudinal
follow-up.
Frailty
A modified version of the Fried’s frailty phenotype was
used to assess frailty [10]. Patients were classified as frail
if they met at least three of the following conditions: 1)
low self-reported levels of physical activity (PA), assessed
by means of the short-form international physical activ-
ity questionnaire (IPAQ-SF) [22] (total Kcal/week below
an established threshold [10]); 2) low gait speed, assessed
as walking time of 15 ft above an established threshold
[10]; 3) low strength, assessed by means of an isometric
handgrip test below an established threshold [10]; 4)
self-reported exhaustion, assessed by means of the SF-36
questionnaire (vitality score <55) [23]; 5) unintentional
weight loss ≥10 lbs. in the previous 12 months (ascer-
tained through medical records).
Additional objective physical function and physical activity
measures
1) The 3-m timed up and go (TUG) test was used to as-
sess dynamic balance [24]. 2) The 5 repetitions chair sit
to stand test (CSTS-5) was used to assess lower extrem-
ity muscle power [25]. 3) Maximal voluntary isometric
handgrip and leg extension strength were assessed using
a hydraulic hand dynamometer (Jamar Patterson Med-
ical Ltd., USA) and a digital myometer (MIE, Medical
Research Ltd., Leeds, UK): participants performed three
trials interspersed by a one-minute rest and the average
of these was taken for analysis purposes [26–28]. 4) Ob-
jective measures of PA patterns were obtained using the
activPal monitor (PAL Technologies Ltd., Glasgow, UK).
Participants wore this device on the anterior aspect of
the thigh for seven consecutive days and the average
daily time spent standing, number of daily steps, and
number of daily sit to stands were recorded and sum-
marised using the manufacturer’s proprietary software
[29].
Cardiovascular function
The arterial baroreflex was assessed during quiet rest (in
supine position) and in response to a five-minute head-
up tilt test at 60° (HUT-60°) [18]. The Task Force Moni-
tor 3040i (CNSystems, Graz, Austria), was used for the
non-invasive measurement of all haemodynamic and
baroreflex variables [30–32]. Stroke volume (SV), cardiac
output (CO), and total peripheral resistance (TPR) were
recorded by means of impedance cardiography (ICG).
Heart rate (HR), R-R interval (RRI), continuous systolic
(contSBP) and diastolic (contDBP) BP were measured by
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means of 6-lead electrocardiography (ECG) and continu-
ous photoelectric plethysmography.
Baroreflex function variables taken for the analysis
were i) number of up (up-events) and down (down-
events) baroreceptor events, defined as the simultaneous
coupling of a contSBP ramp (+/− 1mmHg for 3 con-
secutive beats) with either an increase or decrease of the
RRI of at least 4 ms. The total number of baroreceptor
events (total-events) were then calculated as the sum of
all down-events and up-events, ii) the down/up/total
baroreceptor effectiveness index (BEI), representing the
ratio of occurred down/up/total baroreceptor events and
detected down/up/total BP ramps expressed as a per-
centage [33], and iii) baroreflex sensitivity (BRS), the
average slope of the regression lines between the RRIs
and the contSBP values resulting from every barorecep-
tor event [34]. All baroreflex and haemodynamic assess-
ments were performed on a non-dialysis day, during the
midweek interval, in order to minimise the influence of
fluid and electrolyte shifts on data collected.
Statistical analysis
Statistical analyses were performed with SPSS (Version
23.0 for Windows, SPSS Inc., Chicago, IL). The
Kolmogorov-Smirnov Test (K-S) was used to assess
whether data were normally distributed. Differences be-
tween fallers and non-fallers in demographic, clinical,
frailty, and cardiovascular characteristics were analysed by
means of a Chi-Squared test for categorical variables, and
by either Mann-Whitney U or independent t-tests, as ap-
propriate, for continuous variables.
The association between baseline factors and the num-
ber of falls recorded during follow-up was analysed by
means of negative binomial regression with an overdis-
persion parameter estimated on the actual distribution
of the dependent variable (i.e. number of falls). All frailty
and cardiovascular factors were initially entered in a uni-
variate negative binomial regression model, and those
factors reaching statistical significance (p-value ≤ .05)
were taken forward to the multivariate stage. The multi-
variate analysis consisted of a first model (Model 1), in
which all factors were adjusted for clinical confounders,
while a second model was designed to assess the second
research hypothesis. In this second model (Model 2),
frailty and physical function factors were adjusted for all
variables in Model 1 and for the cardiovascular function
variable showing the highest correlation (R2) with num-
ber of falls, while cardiovascular factors were adjusted
for all variables in Model 1 and for frailty. In a further
analysis, we calculated the relative change in Akaike’s In-
formation criterion (AIC) to explore the goodness of fit
of negative binomial regression models where only frailty
and cardiovascular function variables were entered
simultaneously.
Sensitivity analyses were undertaken using the receiver
operating characteristic (ROC) analysis of those potential
factors associated with falls (yes or no), and the area
under the curve (AUC) was used to compare the pre-
dictive ability of frailty alone with a model composed of
frailty and a cardiovascular predictor. Statistical limits
for significance were set at an alpha level of p ≤ .05.
Results
Study participants
Ninety-three patients undergoing outpatient HD therapy
at the Renal Units provided written informed consent.
Seventeen patients (18.3%) did not complete baseline as-
sessments due to i) change of mind or inability to sched-
ule an assessment appointment within a couple of
months from consent (n = 7; 7.5%), ii) deterioration of
health conditions (n = 6; 6.5%) and iii) death (n = 4;
4.3%). The remaining 76 patients completed all baseline
assessments and were enrolled in the study. Seven par-
ticipants (9.2%) were lost to follow-up due to renal
transplantation (n = 4; 5.3%) and death (n = 3; 3.9%).
Therefore, 69 patients were entered in the final analysis.
Demographic and clinical characteristics
The demographic and clinical characteristics of study
participants are summarised in Table 1. Fallers were
more likely to be prescribed antidepressants, and had
significantly higher CRP compared to non-fallers. No
statistically significant differences in other clinical char-
acteristics were detected.
Falls
A total number of 80 falls were recorded during the 12-
month observational follow-up. Figure 1 shows the dis-
tribution of number of falls while Fig. 2 displays the
characteristics of the falls experienced by study
participants.
Frailty and physical function
The frailty and physical function characteristics of study
participants are summarised in Table 2. Fallers were
more likely to meet the frailty component of self-
reported exhaustion.
Cardiovascular function
The cardiovascular function characteristics of study par-
ticipants at rest are summarised in Table 3, while the
haemodynamic responses to HUT-60° are reported in
Table 4.
Predictors of falls
The results from the negative binomial regression ana-
lyses are summarised in Table 5. All frailty/physical
function and cardiovascular function factors reaching
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Table 1 Demographic and clinical characteristics of study participants: results are expressed as percentages for categorical variables









Sex (% M) 55.1 42.3 62.8 0.097
Age (years) 61.7 ± 13.3 58.3 ± 14.1 63.8 ± 12.6 0.151
Weight (kg) 80.3 ± 18.7 75.7 ± 18.6 83.1 ± 18.5 0.114
Height (cm) 166.2 ± 9 166 ± 9 166.3 ± 9 0.892
BMI (kg * m−2) 29.1 ± 6.4 27.6 ± 7 30 ± 5.9 0.144
Clinical history
Dialysis vintage (days) 713 ± 714 732 ± 636 701 ± 765 0.465
CCI (score) 5.3 ± 2.2 5.1 ± 2.1 5.4 ± 2.3 0.639
Primary renal disease (%)
Diabetic nephropathy 25 26.9 23.8 0.773
Glomerulonephritis 19.1 19.2 19 1.000
Polycystic kidney 8.8 0 14.3 0.075
Renovascular or hypertensive 8.8 0 14.3 0.075
Other 20.6 23.1 19 0.690
Uncertain aetiology 17.6 30.8 9.5 0.046
Type of vascular access (%)
Arteriovenous fistula 64.7 61.5 66.7 0.667
Central-venous 35.3 38.5 33.3 0.667
Inter-dialytic weight gain (kg) 1.6 ± 1.2 1.6 ± 1 1.6 ± 1.4 0.923
Ultrafiltration rate (mL/kg/h) 6.5 ± 2.4 7.1 ± 2.5 6.1 ± 2.3 0.095
HD treatment time (h) 4.1 ± 0.5 4.1 ± 0.4 4.2 ± 0.5 0.395
Prescribed medications
Medications (n°) 11.8 ± 3.4 12.4 ± 3.3 11.5 ± 3.5 0.262
Beta blockers use (%) 50 42.3 54.8 0.318
ACE-inhibitors use (%) 7.4 7.7 7.1 1.000
Ca-channel blockers use (%) 57.4 50 61.9 0.335
AngII-receptor antagonists use (%) 16.2 11.5 19 0.512
Alpha blockers use (%) 32.4 38.5 28.6 0.397
Antihypertensive use (%) 83.8 80.8 85.7 0.737
> 1 antihypertensive use (%) 51.5 42.3 57.1 0.234
Opiates use (%) 19.1 11.5 23.8 0.342
Antidepressants use (%) 33.8 50 23.8 0.027
Diuretics use (%) 33.8 23.1 40.5 0.141
Laboratory values
Hb (g/dL) 11.2 ± 1.2 11 ± 1 11.2 ± 1.2 0.317
CRP (mg/L) 25.8 ± 45.4 37.6 ± 59.2 18.3 ± 32.7 0.027
Bicarbonate (mmol/L) 21.2 ± 3.2 21.5 ± 3.1 21.1 ± 3.4 0.546
Na (mmol/L) 139 ± 2.8 138.4 ± 3.3 139.4 ± 2.4 0.388
K (mmol/L) 4.6 ± 0.7 4.6 ± 0.7 4.6 ± 0.6 0.992
Urea (mg/dL) 16.4 ± 5.1 15.7 ± 6.1 16.7 ± 4.5 0.276
Phosphate (mmol/L) 1.5 ± 0.6 1.5 ± 0.6 1.5 ± 0.5 0.978
PTH (ρmol/L) 27.2 ± 32.1 28.9 ± 43.4 26.2 ± 23.1 0.586
Albumin (g/L) 37.1 ± 4.3 36.1 ± 5.2 37.7 ± 3.7 0.146
Adjusted calcium (mmol/L) 2.4 ± 0.1 2.3 ± 0.1 2.4 ± 0.1 0.511
URR (%) 71.1 ± 6.2 71.1 ± 7.7 71 ± 5.1 0.994
Creatinine (μmol/L) 638.1 ± 161.3 592 ± 175.7 666 ± 147.1 0.064
Abbreviations: BMI body mass index, CCI Charlson comorbidity index, HD haemodialysis, ACE angiotensin-converting enzyme, Ca calcium, AngII
angiotensin II, Hb hemoglobin, CRP C-reactive protein, Na sodium, K potassium, PTH parathyroid hormone, URR urea reduction ratio
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statistical significance in univariate analysis were ad-
justed in Model 1 for CRP and antidepressant use, as
both of these clinical factors have been linked to an in-
creased risk of falling in CKD-5 [1, 15]. Moreover, with
concern for multi-collinearity (Additional file 1: Table
S1), we only reported the baroreflex function index
showing the highest correlation with number of falls
(total-BEI). In fully adjusted analyses (Model 2), total-
BEI, and the haemodynamic response of OscDBP to
HUT-60° were associated with a higher number of falls.
Table 6 shows the goodness of fit (AIC) of the univari-
ate regression models and its relative change following
forced entry modelling of frailty and cardiovascular
function (multivariate stage). The model composed of
Fig. 1 Distribution of number of falls in the study participants
Fig. 2 Characteristics of falls experienced by the study participants
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frailty and total-BEI resulted in a 19.1% decrease in AIC
compared to frailty alone.
Sensitivity analyses
Figure 3 shows the ROC curves of frailty alone and the
model composed of frailty and total-BEI. Frailty alone
did not discriminate significantly fallers from non-fallers,
while adding the cardiovascular variable total-BEI re-
sulted in a significant improvement of the AUC (+ 6%).
In a further sensitivity analysis (Additional file 1: Table
S2), we re-ran the negative binomial regression analysis
adjusting Model 1 for diabetes, a well-established risk
factor for falls in HD patients [1]. In this additional ana-
lysis, only total-BEI remained significantly associated
with a higher number of falls (RR: 0.97, 95%CI: 0.95–
0.99, p = 0.02).
Discussion
We hypothesised that frailty and cardiovascular function
would be associated with a higher number of falls in
CKD-5 patients on HD. Additionally, we hypothesised
that modelling the risk of falling by adding a cardiovas-
cular function variable to frailty would improve the pre-
diction of falls sustained over 12 months in this patient
population.
The univariate negative binomial regression analysis re-
vealed that frailty and other physical function measures,
such as number of daily steps and sit to stands, handgrip
strength, gait speed, and TUG were associated with a
higher number of falls in the study population. In
addition, cardiovascular function indices such as total-BEI,
CO and OscDBP responses to HUT-60°, were also associ-
ated with a higher number of falls (Table 5). However, in
multivariate analysis, only total-BEI and the OscDBP re-
sponse to HUT-60° were significantly predictive of a
greater number of falls. In addition, modelling the risk of
falling by adding a cardiovascular function index (total-
BEI) to frailty resulted in a 19.1% reduction in AIC, indi-
cating a better goodness of fit, while adding frailty to car-
diovascular indices such as total-BEI, CO and OscDBP
responses to HUT-60°, hardly modified the AICs (− 0.8%
to − 1.7%, Table 6). Moreover, the sensitivity analyses per-
formed by means of ROC curve analysis revealed that add-
ing total-BEI to the frailty model corresponded to a net
6% improvement of the AUC and resulted in a statistically
significant prediction of falling status (Fig. 3).
The overall implications of these findings are that the
addition of a baroreflex function index to an exclusively
physical frailty-based model, did not only improve the
prediction of falls, but it also highlighted the greater
relative importance of a cardiovascular function index,
implicated in the short-term regulation of BP, in predict-
ing the occurrence of these falls. In particular, the forced
entry modelling performed in Model 2 of the negative
Table 2 Frailty and physical function characteristics of study participants: results are expressed as percentages for categorical








Frailty components and phenotype
Low PA (%) 47.8 46.2 48.8 0.829
Low gait speed (%) 29 42.3 20.9 0.058
Low strength (%) 47.8 46.2 48.8 0.829
Exhaustion (%) 73.5 92.3 61.9 0.006
Unintentional weight loss (%) 17.6 28 11.6 0.108
Fried’s frailty phenotype (%) 37.7 50 30.2 0.101
Objectively measured PA
Time spent standing (h) 2.4 ± 1.2 2.1 ± 1.1 2.5 ± 1.2 0.177
Daily steps (n°) 3086 ± 1810 2601 ± 1325 3366 ± 2004 0.144
Daily sit to stands (n°) 37.5 ± 12.6 38.3 ± 16.1 37.1 ± 10.3 0.894
Strength
Handgrip (kg) 26.9 ± 9.5 24.5 ± 10 28.4 ± 9 0.101
Leg extension (kg) 20.1 ± 9 17.4 ± 8.3 21.8 ± 9.1 0.050
Functional tests
Gait speed (m/s) 0.85 ± 0.26 0.78 ± 0.26 0.9 ± 0.25 0.067
TUG (s) 11.5 ± 4.8 13.3 ± 6.4 10.4 ± 3.4 0.055
CSTS-5 (s) 17.1 ± 8.9 19.6 ± 12.3 15.7 ± 6.3 0.355
Abbreviations: PA physical activity, TUG timed up and go test, CSTS-5 5 repetitions chair sit to stand test
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binomial regression analysis (Table 5), as well as the
goodness of fit analysis (Table 6), suggest that lower
baroreflex function and orthostatic decrements of BP
may have an even higher impact than frailty on the pre-
diction of falls in CKD-5 patients on HD.
The predominant role of these cardiovascular factors
appeared to be also indirectly confirmed by the fall-
related symptomatology reported by study participants
(Fig. 2). The most common precipitating factors re-
ported by fallers were dizziness/loss of consciousness
(41.3% of falls), followed by loss of balance/unsteadiness
of the legs (31.3% of falls), and environmental hazards
(20% of falls). These symptoms seem to point out that
the majority of falls were probably related to some
underlying cardiovascular/haemodynamic type of mech-
anism. Because impairments of baroreflex function are
linked to orthostatic decrements of BP [35], the dysregu-
lation of BP during a sudden change in body position, or
during prolonged standing may be one of the main
mechanisms implicated in the aetiology of falls in CKD-
5 patients on HD. Both of these factors predicted a
higher number of falls in our study.
Another interesting finding was that BEI but not BRS
was associated with a higher number of falls. The BEI is
a measure that describes how often the baroreflex is ac-
tivated [36], in contrast to the BRS which represents the
baroreflex gain [37]. Therefore, we plausibly take the
view that frequency, rather than intensity, of baroreflex
activation may contribute more importantly to the in-
creased risk of falling. Due to the fact that many spontan-
eous fluctuations of BP manifest suddenly throughout the
day, as a result of changes in body position or more or less
Table 3 Cardiovascular function characteristics of study participants. Baroreflex and haemodynamic variables at rest: results are









Up-ramps (n°) 20.4 ± 18.9 20.9 ± 22.9 20.1 ± 15.8 0.632
Down-ramps (n°) 18.4 ± 15.9 19.1 ± 18.3 17.9 ± 14.2 0.811
Total-ramps (n°) 38.8 ± 34.3 40 ± 40.7 38 ± 29.8 0.688
Up-events (n°) 4.5 ± 7.1 2.6 ± 3.7 5.7 ± 8.4 0.125
Down-events (n°) 4.8 ± 6.4 3.3 ± 4.5 5.7 ± 7.3 0.347
Total-events (n°) 9.3 ± 13 6 ± 7.9 11.4 ± 15.1 0.129
Up-BEI (%) 20.6 ± 25.2 14.6 ± 20.2 24.7 ± 27.7 0.165
Down-BEI (%) 27.9 ± 26.4 20.3 ± 22.7 32.9 ± 27.7 0.103
Total-BEI (%) 25.4 ± 25 17.7 ± 19.1 30.6 ± 27.4 0.078
BRS (ms/mmHg) 9.3 ± 7.1 10.3 ± 9.3 8.8 ± 5.9 0.806
Haemodynamic variables
RRI (ms) 894.9 ± 163.1 867.7 ± 112.4 911.4 ± 186.8 0.240
HR (bpm) 69.5 ± 12 70.7 ± 9.3 68.8 ± 13.4 0.506
contSBP (mmHg) 124 ± 23.1 127 ± 26.2 122.1 ± 21.1 0.462
contDBP (mmHg) 77.8 ± 14.8 76.8 ± 12.5 78.4 ± 16.1 0.756
contmBP (mmHg) 97.2 ± 17.7 97.9 ± 16.9 96.8 ± 18.4 0.801
SV (ml) 64.4 ± 14.4 63.6 ± 12.1 64.8 ± 15.7 0.921
CO (L/min) 4.4 ± 1.2 4.5 ± 0.9 4.4 ± 1.3 0.416
TPR (dyne*s/cm5) 1777 ± 501 1716 ± 371 1816 ± 570 0.440
SI (ml/m2) 34.8 ± 8.8 35.2 ± 7.8 34.5 ± 9.5 0.455
CI (L/min*m2) 2.4 ± 0.7 2.5 ± 0.5 2.4 ± 0.8 0.167
TPRI(dyne*s*m2/cm5) 3330 ± 1037 3121 ± 710 3464 ± 1190 0.154
TFC (1/kΩ) 32.9 ± 10.8 34.6 ± 12.1 31.9 ± 10 0.365
OscSBP (mmHg) 128.2 ± 22 134.4 ± 26.3 124.8 ± 18.7 0.094
OscDBP (mmHg) 81 ± 13.9 82.4 ± 12.8 80.2 ± 14.5 0.553
Abbreviations: Up-BEI up-events baroreceptor effectiveness index, Down-BEI down-events baroreceptor effectiveness index, Total-BEI total-events baroreceptor
effectiveness index, BRS baroreflex sensitivity, RRI R-R interval, HR heart rate, contSBP continuous systolic blood pressure, contDBP continuous diastolic blood
pressure, contmBP continuous mean blood pressure, SV stroke volume, CO cardiac output, TPR total peripheral resistance, SI stroke index, CI cardiax index, TPRI
total peripheral resistance index, TFC thoracic fluid content, OscSBP oscillometric systolic blood pressure, OscDBP oscillometric diastolic blood pressure
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prolonged periods of standing [38], the baroreflex has to
constantly adjust HR and peripheral resistance to maintain
cardiac output. Thus, a reduced frequency of baroreflex
activation (i.e. low BEI) would imply that sudden drops in
BP are not coupled effectively with concomitant increases
of HR, which may result in a suboptimal cerebral perfu-
sion possibly leading to dizziness symptoms and, conse-
quently, falls [39].
Many dialysis-specific or idiopathic risk factors may be
involved in the dysregulation of BP which could possibly
lead to dizziness symptoms and falls in this clinical popu-
lation. First of all, the uremia-related cardiac autonomic
dysfunction, characterised by alterations of the sympa-
thetic, parasympathetic, and baroreflex components of the
autonomic nervous system, is a factor that has been linked
to symptomatic hypotension in CKD-5 patients [40].
Moreover, autonomic neuropathy is a common clinical
complication of advanced diabetes, the most common
cause of CKD [41], and it can also lead to a diminished re-
sponse of BP to standing [42]. Secondly, dialysis patients
are often treated with one or more antihypertensive drugs
(83.8 and 51.5% of patients in our study). While this is
often an unavoidable therapy for the treatment of hyper-
tension, such antihypertensive polypharmacy has been
linked to an increased risk of falling by inducing dizziness
and postural hypotension [43].
Importantly, a systematic review with meta-analysis
has recently concluded that exercise training can ameli-
orate autonomic regulation in CKD patients [44]. In par-
ticular, Petraki et al. [20] have shown that a seven-
month intradialytic exercise programme led to improve-
ments amounting to 27–35% in number of baroreceptor
events and BEI in CKD-5 patients on HD. Since such
measures were predictive of a higher number of falls in
our study (Table 5), this raises the question as to
whether an exercise training intervention may reduce
the risk of falling by improving indices of autonomic
function in people affected by CKD-5. Further research
is warranted to explore this hypothesis as well as the
cost-effectiveness of this potential intervention strategy.
The estimates of association between frailty and num-
ber of falls experienced emerging from this study are
similar to those observed by previous research [4, 12]. In
particular, McAdams-DeMarco et al. [4] explored the as-
sociation between the Fried’s frailty phenotype and num-
ber of falls sustained over 6 months. The authors found
that frailty was associated with a roughly 3.5 times
higher number of falls in univariate Poisson regression
analysis, an estimate that echoes the results from the
univariate negative binomial regression analysis in our
study (Table 5). Therefore, we conclude that our find-
ings on the relationship between frailty and falls exhibit
good external validity and may be generalised to the
wider population of CKD-5 patients receiving HD.
Interestingly, the exploratory independent compari-
sons of fallers and non-fallers revealed that those who
fell were more likely to use antidepressants (50% vs
23.8%) and had higher CRP levels (37.6 ± 59.2 mg/L vs
18.3 ± 32.7 mg/L). Because both antidepressant use and
high CRP levels have been linked to a higher risk of
Table 4 Haemodynamic responses to HUT-60°. Difference between the variables averaged over 5 min of HUT-60° and the variables








RRI (ms) −60.4 ± 66.8 −55.9 ± 71.1 −63 ± 65 0.514
HR (bpm) 6.2 ± 7.3 6.9 ± 9.6 5.8 ± 5.7 0.860
contSBP (mmHg) 3.9 ± 11.9 4.8 ± 14.9 3.4 ± 9.9 0.178
contDBP (mmHg) 6.3 ± 8.5 6.3 ± 10.6 6.3 ± 7.1 0.575
contmBP (mmHg) 5.3 ± 9.4 5.4 ± 12 5.2 ± 7.8 0.436
SV (ml) −4.1 ± 13.8 −4.5 ± 12.7 −3.9 ± 14.5 0.693
CO (L/min) 0.01 ± 1 0 ± 0.9 0.02 ± 1 0.734
TPR (dyne*s/cm5) 98.3 ± 374.8 102.8 ± 367.4 95.5 ± 384.1 0.941
SI (ml/m2) −2.3 ± 7.6 −2.3 ± 6.9 −2.3 ± 8 0.703
CI (L/min*m2) −0.01 ± 0.5 0.01 ± 0.5 −0.01 ± 0.5 0.887
TPRI(dyne*s*m2/cm5) 173.7 ± 684 193.8 ± 655.3 161.3 ± 709.3 0.856
TFC (1/kΩ) −1.9 ± 1.8 − 2 ± 1.9 −1.8 ± 1.8 0.632
OscSBP (mmHg) −3.6 ± 9.8 −5.6 ± 10.9 −2.5 ± 9 0.249
OscDBP (mmHg) −0.7 ± 6.9 −2.6 ± 7.5 0.3 ± 6.4 0.432
Abbreviations: RRI R-R interval, HR: heart rate, contSBP continuous systolic blood pressure, contDBP continuous diastolic blood pressure, contmBP continuous mean
blood pressure, SV stroke volume, CO cardiac output, TPR total peripheral resistance, SI stroke index, CI cardiax index, TPRI total peripheral resistance index, TFC
thoracic fluid content, OscSBP oscillometric systolic blood pressure, OscDBP oscillometric diastolic blood pressure
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falling by previous research conducted on HD patients
[1, 15], we adjusted the analysis for these possible clin-
ical confounders (Model 1). In this first model of multi-
variate analysis, neither frailty nor the additional
physical function measures were significantly associated
with a higher number of falls (Table 5). This finding fur-
ther reinforces the observation that total-BEI and the
OscDBP response to HUT-60° had a greater relative im-
portance than frailty in predicting the number of falls
experienced by study participants during the 12-month
follow up.
It should be acknowledged that because the sample size
was relatively small, we could not apply a more exhaustive
multivariate negative binomial regression analysis to more
robustly test the interrelationships between frailty/physical
function, cardiovascular function, and falls. In addition,
we should also acknowledge that, while orthostatic decre-
ments of OscDBP were significantly associated with falls
(Table 5), orthostatic decrements of OscSBP were not.
However, in univariate negative binomial regression ana-
lysis, OscSBP decrements also exhibited a potential trend
of association with falls (RR: 0.95, 95%CI: 0.89–1.01, p =
0.084), and it is possible that a larger sample size may have
also resulted into better chances of detecting a significant
association between OscSBP decrements and falls, by de-
creasing the chances of committing a type II error. The
Table 5 Negative binomial regression analysis: predictors of falls
Factors Univariate Multivariate
Model 1 Model 2
RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value
Frailty & physical function
Frailty (yes/no) 4.10 (1.60–10.51) 0.003 2.23 (0.85–5.87) 0.103 1.78 (0.70–4.51) 0.224
Daily steps (n°) 0.99 (0.99–1.00) 0.006 1.00 (0.99–1.00) 0.137 1.00 (0.99–1.00) 0.106
Daily sit to stands (n°) 0.96 (0.93–0.99) 0.042 0.98 (0.94–1.02) 0.387 0.99 (0.95–1.04) 0.707
Handgrip (kg) 0.94 (0.88–0.99) 0.034 0.97 (0.92–1.02) 0.216 0.98 (0.93–1.04) 0.448
Gait speed (m/s) 0.08 (0.01–0.62) 0.016 0.26 (0.03–2.08) 0.205 0.36 (0.04–3.32) 0.363
TUG (s) 1.16 (1.02–1.32) 0.021 1.08 (0.96–1.21) 0.220 1.03 (0.91–1.17) 0.643
Cardiovascular function
Total-BEI (%) 0.96 (0.93–0.98) <0.001 0.96 (0.94–0.99) 0.003 0.96 (0.94–0.99) 0.004
CO (L/min) 0.51 (0.27–0.98) 0.043 0.66 (0.37–1.15) 0.143 0.67 (0.39–1.13) 0.134
OscDBP (mmHg) 0.90 (0.83–0.98) 0.010 0.93 (0.87–0.99) 0.036 0.93 (0.87–0.99) 0.033
Abbreviations: RR rate ratio, CI confidence interval, TUG timed up and go test, Total-BEI total-events baroreceptor effectiveness index, CO cardiac output response
to HUT-60°, OscDBP oscillometric diastolic blood pressure response to HUT-60°, Model 1: All factors are adjusted for CRP and antidepressant use, Model 2 Frailty
and physical function factors are adjusted for all variables in Model 1 and for Total-BEI. Cardiovascular function factors are adjusted for all variables in Model 1
and for frailty
Table 6 Further analyses: goodness of fit of negative binomial regression models
Factors Univariate Multivariatea
RR (95% CI) P-value AIC RR (95% CI) P-value AIC ΔAIC
Frailty and physical function
Frailty (yes/no) 4.10 (1.60–10.5) 0.003 185 2.53 (0.96–6.70) 0.060 149.6 −19.1%
Daily steps (n°) 0.99 (0.99–1.00) 0.006 142.3 1.00 (0.99–1.00) 0.036 113.2 −20.4%
Daily sit to stands (n°) 0.96 (0.93–0.99) 0.042 146.7 0.99 (0.95–1.03) 0.543 116.7 − 20.4%
Handgrip (kg) 0.94 (0.88–0.99) 0.034 188.6 0.97 (0.91–1.03) 0.330 151.8 −19.5%
Gait speed (m/s) 0.08 (0.01–0.62) 0.016 176.3 0.14 (0.02–1.39) 0.094 141.1 −20.0%
TUG (s) 1.16 (1.02–1.32) 0.021 171.7 1.10 (0.95–1.27) 0.226 138.5 −19.3%
Cardiovascular function
Total-BEI (%) 0.96 (0.93–0.98) <0.001 150.8 0.96 (0.94–0.99) 0.003 149.6 −0.8%
CO (L/min) 0.51 (0.27–0.98) 0.043 168.6 0.58 (0.33–1.04) 0.068 165.7 −1.7%
OscDBP (mmHg) 0.90 (0.83–0.98) 0.010 144.1 0.92 (0.85–0.99) 0.028 142.6 −1.0%
Abbreviations: RR rate ratio, CI confidence interval, AIC Akaike’s information criterion, TUG timed up and go test, Total-BEI total-events baroreceptor effectiveness
index, CO cardiac output, OscDBP oscillometric diastolic blood pressure
aFrailty and physical function variables are adjusted by Total-BEI, cardiovascular function variables are adjusted by frailty
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lack of relationship between contBP and falls may also be
explained in light of the orthostatic challenge used in our
study, as previous research has shown that the initial re-
sponse of contBP to passive tilting is less pronounced or
even absent compared to active stand procedures [45, 46].
Additionally, the relatively short duration of HUT-60°
may be partially responsible for the apparent lack of differ-
ence in BP response during the orthostatic challenge in
fallers compared with non-fallers (Table 4). Particularly,
the five-minute HUT-60° protocol employed in this study
was designed to investigate only the short-lived haemo-
dynamic adjustments to orthostasis [18, 47]. Previous re-
search has shown that, during a 15-min passive
orthostatic challenge, elderly people with a history of falls
tend to exhibit a larger drop of BP compared with non-
fallers [39]. Therefore, it is plausible that a longer HUT-
60° protocol may have revealed a larger decrement of both
contBP and OscBP in fallers [46].
Conclusions
This prospective cohort study indicates that by adding a
cardiovascular index, implicated in the short-term regu-
lation of BP, to a frailty-only model it was possible to
improve significantly the prediction of falls in CKD-5
patients on HD. Baroreflex function, as assessed by
means of BEI, and orthostatic decrements of BP showed
a higher impact, and thus greater relative importance,
than frailty in predicting number of falls in the study
population. The clinical implications of these findings
indicate that a simple non-invasive, time-efficient, as-
sessment consisting of a continuous and simultaneous
recording of BP and HR may be more useful than frailty
assessment alone when predicting falls in HD patients.
A high number of falls appear to be mediated by a de-
gree of cardiovascular dysregulation, evidenced by the
predominance of self-reported dizziness symptoms. We
therefore recommend that interventions designed to im-
prove baroreflex function/short-term regulation of BP
should be considered when implementing falls preven-
tion programmes in this patient population.
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